Cargando…
Efficacy and Safety of Shenqisuxin Granule for Non-ST-segment Elevation Acute Coronary Syndrome: Study Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial
INTRODUCTION: The Chinese herbal compound formula, Shenqisuxin granule (SQSX), promotes neovascularization and prevents in-stent restenosis in modern pharmaceutical studies and is expected to provide an effective strategy for non-ST-segment elevation acute coronary syndrome (NSTEACS). Thus, this stu...
Autores principales: | Wu, Xiaoping, Guo, Ming, Shi, Shihua, Shi, Shengnan, Deng, Yanping, Wang, Shenglan, Wang, Yabing, Wang, Peili, Chen, Keji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218484/ https://www.ncbi.nlm.nih.gov/pubmed/35757330 http://dx.doi.org/10.3389/fcvm.2022.888724 |
Ejemplares similares
-
A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol
por: Wu, Xiaoping, et al.
Publicado: (2022) -
Diffuse ST-segment elevation beyond acute coronary syndrome
por: Zhu, Hai, et al.
Publicado: (2023) -
Case Report: ST-Segment Elevation in a Man With Acute Pericarditis
por: Li, Yi-Ming, et al.
Publicado: (2020) -
ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION SECONDARY TO COVID-19
por: DOUEDI, STEVEN, et al.
Publicado: (2021) -
A cohort study of circulating progenitor cells after ST-segment elevation and non-ST segment elevation myocardial infarction in non-diabetic and diabetic patients
por: Baumbach, Andreas, et al.
Publicado: (2022)